Trial Profile
Phase II Trial of Induction Therapy With Docetaxel, Cisplatin and Fluorouracil in Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma and/or Poorly Differentiated Carcinoma of the Nasal Cavity and/or Paranasal Sinuses
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Carboplatin; Cisplatin; Fluorouracil
- Indications Adenocarcinoma; Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 18 Sep 2023 Planned End Date changed from 30 Sep 2023 to 30 Sep 2024.
- 18 Sep 2023 Planned primary completion date changed from 30 Sep 2023 to 30 Sep 2024.
- 18 Sep 2023 Status changed from recruiting to active, no longer recruiting.